The European Medicines Agency’s (EMA) human medicines committee (CHMP) recommended another batch medicines for approval at ...
Merck & Co.’s kidney cancer drug Welireg, Bayer and BridgeBio’s transthyretin amyloid cardiomyopathy (ATTR-CM) therapy, and ...
TORONTO, Dec. 13, 2024 (GLOBE NEWSWIRE) -- On December 13, 2024, the Board of Directors of AGF Management Limited declared a ...
BridgeBio Pharma (BBIO) announced the Committee for Medicinal Products for Human Use or CHMP has adopted a positive opinion ...
Bayer AG won the backing of European Union regulators for its cardiology drug as the German company fights to offset the ...
The Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of acoramidis in the EU based on ...
BridgeBio Pharma (BBIO) announced that the Committee for Medicinal Products for Human Use has adopted a positive opinion recommending marketing authorization in the European Union for acoramidis for ...
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
North Health Ltd. raised $6 million in financing to bring its oncology products to the market including the Neutrocheck, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback